Functional characteristics of coronary vasomotor function following intramyocardial gene therapy with naked DNA encoding for vascular endothelial growth factor165

Endothelium: Journal of Endothelial Cell Research

Volumn 12, Issue 3, 2005, Pages 103-106

  Tio, Ren A ^a   Wijpkema, Jasper S ^a   Tan, Eng S ^a   Asselbergs, Folkert W ^a   Hospers, Geke A P ^a   Jessurun, Gillian A J ^a   Zijlstra, Felix ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Acetylcholine; Angiogenesis; Endothelium; Gene therapy; VEGF

Indexed keywords

ACETYLCHOLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NAKED DNA; NITRATE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165;

ADRENERGIC SYSTEM; ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; ENDOTHELIUM; FEMALE; FOLLOW UP; GENETIC CODE; HEART VENTRICLE FILLING; HUMAN; MALE; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACETYLCHOLINE; AGED; ANGIOPLASTY, BALLOON; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DNA; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; GENE THERAPY; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATOR AGENTS;

EID: 27544465879     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320500191745     Document Type: Article

References (7)

1. Asselbergs F.W., Monnink S.H., Veeger N.J., van Boven A.J., van Haelst P.L., Jessurun G.A., van Gilst W.H., and Tio R.A. (2004) Coronary vasomotor response is related to the angiographic extent of coronary sclerosis in patients with stable angina pectoris. Clinical Science (London), 106, 115-120.
2. Drexler H., and Zeiher A.M. (1991) Progression of coronary endothelial dysfunction in man and its potential clinical significance. Basic Research in Cardiology, 86(Suppl 2), 223-232.
3. Inoue M., Itoh H., Ueda M., Naruko T., Kojima A., Komatsu R., Doi K., Ogawa Y., Tamura N., Takaya K., Igaki T., Yamashita J., Chun T.H., Masatsugu K., Becker A.E., and Nakao K. (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation, 98, 2108-2116.
4. Kroll J., and Waltenberger J. (1998) VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochemical Biophysical Research Communications, 252, 743-746.
5. Tio R.A., Tan E.S., Jessurun G.A., Veeger N., Jager P.L., Slart R.H., de Jong R.M., Pruim J., Hospers G.A., Willemsen A.T., de Jongste M.J., van Boven A.J., van Veldhuisen D.J., and Zijlstra F. (2004) PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease. Journal of Nuclear Medicine, 45, 1437-1443.
6. Tio R.A., Tkebuchava T., Scheuermann T.H., Lebherz C., Magner M., Kearny M., Esakof D.D., Isner J.M., and Symes J.F. (1999) Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Human Gene Therapy, 10, 2953-2960.
7. Vale P.R., Losordo D.W., Milliken C.E., McDonald M.C., Gravelin L.M., Curry C.M., Esakof D.D., Maysky M., Symes J.F., and Isner J.M. (2001) Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation, 103, 2138-2143.